<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 25, 2026 at 9:30 AM by All in One SEO v4.9.6.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Thu, 23 Apr 2026 04:31:27 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/puretech-reports-positive-lyt-200-phase-1b-trial-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/puretech-reports-positive-lyt-200-phase-1b-trial-data/]]></link>
			<title>PureTech Reports Positive LYT-200 Phase 1b Trial Data</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 04:31:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/novartis-coartem-baby-wins-who-nod-for-infant-malaria/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/novartis-coartem-baby-wins-who-nod-for-infant-malaria/]]></link>
			<title>Novartis Coartem Baby Wins WHO Nod for Infant Malaria</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:49:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/amphista-targeted-glue-data-shows-tumor-regression/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/amphista-targeted-glue-data-shows-tumor-regression/]]></link>
			<title>Amphista Targeted Glue Data Shows Tumor Regression</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:44:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/johnson-johnson-imaavy-delivers-2-year-gmg-control/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/johnson-johnson-imaavy-delivers-2-year-gmg-control/]]></link>
			<title>Johnson &amp; Johnson IMAAVY Delivers 2-Year gMG Control</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:36:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/fda-fast-tracks-psychedelic-therapies-for-mental-illness/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/fda-fast-tracks-psychedelic-therapies-for-mental-illness/]]></link>
			<title>FDA Fast-Tracks Psychedelic Therapies for Mental Illness</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:32:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/wuxi-biologics-chengdu-plant-set-for-gmp-biologics-output/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/wuxi-biologics-chengdu-plant-set-for-gmp-biologics-output/]]></link>
			<title>WuXi Biologics Chengdu Plant Set for GMP Biologics Output</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:24:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/mabwell-9mw2821-advances-to-phase-iii-in-tnbc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/mabwell-9mw2821-advances-to-phase-iii-in-tnbc-trial/]]></link>
			<title>Mabwell 9MW2821 Advances to Phase III in TNBC Trial</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:33:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anaxiom-avos-device-shows-safe-early-obesity-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anaxiom-avos-device-shows-safe-early-obesity-results/]]></link>
			<title>Anaxiom AVOS Device Shows Safe Early Obesity Results</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:24:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/telomir-acquires-teli-to-secure-global-telomir-1-rights/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/telomir-acquires-teli-to-secure-global-telomir-1-rights/]]></link>
			<title>Telomir Acquires TELI to Secure Global Telomir-1 Rights</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:13:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/abbvie-1-4b-durham-campus-to-boost-us-drug-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/abbvie-1-4b-durham-campus-to-boost-us-drug-manufacturing/]]></link>
			<title>AbbVie $1.4B Durham Campus to Boost US Drug Manufacturing</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:06:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/haemonetics-vascade-mvp-xl-shows-superior-closure/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/haemonetics-vascade-mvp-xl-shows-superior-closure/]]></link>
			<title>Haemonetics VASCADE MVP XL Shows Superior Closure</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:02:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/sanofi-cenrifki-wins-eu-chmp-boost-for-progressive-ms/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/sanofi-cenrifki-wins-eu-chmp-boost-for-progressive-ms/]]></link>
			<title>Sanofi Cenrifki Wins EU CHMP Boost for Progressive MS</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:52:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/kyowa-kirin-kura-oncology-launch-ziftomenib-aml-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/kyowa-kirin-kura-oncology-launch-ziftomenib-aml-trial/]]></link>
			<title>Kyowa Kirin, Kura Oncology Launch Ziftomenib AML Trial</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:43:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/regeneron-otarmeni-gene-therapy-fda-hearing-breakthrough/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/regeneron-otarmeni-gene-therapy-fda-hearing-breakthrough/]]></link>
			<title>Regeneron Otarmeni Gene Therapy FDA Hearing Breakthrough</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:32:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/flex-vessel-prep-shows-strong-12-month-outcomes/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/flex-vessel-prep-shows-strong-12-month-outcomes/]]></link>
			<title>FLEX Vessel Prep Shows Strong 12-Month Outcomes</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:23:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/novo-nordisk-oral-semaglutide-shows-pediatric-breakthrough/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/novo-nordisk-oral-semaglutide-shows-pediatric-breakthrough/]]></link>
			<title>Novo Nordisk Oral Semaglutide Shows Pediatric Breakthrough</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:52:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/merck-partners-with-google-cloud-for-1b-ai-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/merck-partners-with-google-cloud-for-1b-ai-platform/]]></link>
			<title>Merck Partners with Google Cloud for $1B AI Platform</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:36:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/regeneron-sanofi-secure-fda-approval-for-dupixent-in-pediatric-csu/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/regeneron-sanofi-secure-fda-approval-for-dupixent-in-pediatric-csu/]]></link>
			<title>Regeneron &amp; Sanofi Secure FDA Approval for Dupixent in Pediatric CSU</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:31:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/dogwood-therapeutics-secures-100m-partnership-for-antiviral-assets/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/dogwood-therapeutics-secures-100m-partnership-for-antiviral-assets/]]></link>
			<title>Dogwood Therapeutics Secures $100M Partnership for Antiviral Assets</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:23:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/atrium-therapeutics-earns-15m-milestone-from-bristol-myers-squibb/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/atrium-therapeutics-earns-15m-milestone-from-bristol-myers-squibb/]]></link>
			<title>Atrium Therapeutics Earns $15M Milestone from Bristol Myers Squibb</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 07:06:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/philips-launches-bridge-plus-for-critical-cardiac-safety/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/philips-launches-bridge-plus-for-critical-cardiac-safety/]]></link>
			<title>Philips Launches Bridge Plus for Critical Cardiac Safety</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:52:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/renovorx-showcases-tamp-platform-data-at-asco-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/renovorx-showcases-tamp-platform-data-at-asco-2026/]]></link>
			<title>RenovoRx Showcases TAMP Platform Data at ASCO 2026</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:47:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/repertoire-immune-medicines-doses-first-patient-in-phase-1-2-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/repertoire-immune-medicines-doses-first-patient-in-phase-1-2-trial/]]></link>
			<title>Repertoire Immune Medicines Doses First Patient in Phase 1/2 Trial</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:42:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/astrazenecas-ultomiris-shows-phase-3-breakthrough-in-igan/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/astrazenecas-ultomiris-shows-phase-3-breakthrough-in-igan/]]></link>
			<title>AstraZeneca’s Ultomiris Shows Phase 3 Breakthrough in IgAN</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:31:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/invita-hemaconnect-2-5-boosts-cgt-donor-recruitment/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/invita-hemaconnect-2-5-boosts-cgt-donor-recruitment/]]></link>
			<title>InVita HemaConnect 2.5 Boosts CGT Donor Recruitment</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:30:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/aspira-womens-health-expands-lab-to-advance-endoinform-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/aspira-womens-health-expands-lab-to-advance-endoinform-test/]]></link>
			<title>Aspira Women’s Health Expands Lab to Advance ENDOinform Test</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 06:14:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/mozart-therapeutics-shows-disease-modifying-potential-in-phase-1-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/mozart-therapeutics-shows-disease-modifying-potential-in-phase-1-trial/]]></link>
			<title>Mozart Therapeutics Shows Disease-Modifying Potential in Phase 1 Trial</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 05:26:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/johnson-johnson-imaavy-shows-strong-phase-3-gmg-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/johnson-johnson-imaavy-shows-strong-phase-3-gmg-data/]]></link>
			<title>Johnson &amp; Johnson IMAAVY Shows Strong Phase 3 gMG Data</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 07:03:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/utepreva-secures-fda-clearance-for-advanced-endometrial-sampler/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/utepreva-secures-fda-clearance-for-advanced-endometrial-sampler/]]></link>
			<title>Utepreva Secures FDA Clearance for Advanced Endometrial Sampler</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 05:18:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/thryv-therapeutics-targets-lqts-with-thrv-1268-trial-launch/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/thryv-therapeutics-targets-lqts-with-thrv-1268-trial-launch/]]></link>
			<title>Thryv Therapeutics Targets LQTS with THRV-1268 Trial Launch</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 06:56:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/biotia-validates-ai-ngs-test-for-accurate-uti-detection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/biotia-validates-ai-ngs-test-for-accurate-uti-detection/]]></link>
			<title>Biotia Validates AI-NGS Test for Accurate UTI Detection</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 05:12:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/genentech-reports-strong-phase-3-enspryng-data-in-mogad/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/genentech-reports-strong-phase-3-enspryng-data-in-mogad/]]></link>
			<title>Genentech Reports Strong Phase 3 Enspryng Data in MOGAD</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 08:05:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/philips-boosts-cancer-imaging-with-rembra-fda-clearance/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/philips-boosts-cancer-imaging-with-rembra-fda-clearance/]]></link>
			<title>Philips Boosts Cancer Imaging with Rembra FDA Clearance</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 07:59:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/abbisko-pimicotinib-nda-progress-advances-tgct-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/abbisko-pimicotinib-nda-progress-advances-tgct-therapy/]]></link>
			<title>Abbisko Pimicotinib NDA Progress Advances TGCT Therapy</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 07:46:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/adial-ad04-manufacturing-milestone-supports-phase-3/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/adial-ad04-manufacturing-milestone-supports-phase-3/]]></link>
			<title>Adial AD04 Manufacturing Milestone Supports Phase 3</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 07:28:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/phanes-therapeutics-shows-progress-in-pdac-with-spevatamig/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/phanes-therapeutics-shows-progress-in-pdac-with-spevatamig/]]></link>
			<title>Phanes Therapeutics Shows Progress in PDAC with Spevatamig</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 07:07:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/demerx-gains-fda-ind-clearance-for-dmx-1001-in-aud/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/demerx-gains-fda-ind-clearance-for-dmx-1001-in-aud/]]></link>
			<title>DemeRx Gains FDA IND Clearance for DMX-1001 in AUD</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 05:10:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/ipsen-wins-eu-approval-for-ojemda-in-pediatric-glioma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/ipsen-wins-eu-approval-for-ojemda-in-pediatric-glioma/]]></link>
			<title>Ipsen Wins EU Approval for Ojemda in Pediatric Glioma</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 06:45:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/astrin-earns-cap-for-breast-cancer-blood-test-launch/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/astrin-earns-cap-for-breast-cancer-blood-test-launch/]]></link>
			<title>Astrin Earns CAP for Breast Cancer Blood Test Launch</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 05:05:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/sonorous-neurovascular-advances-care-with-boscath-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/sonorous-neurovascular-advances-care-with-boscath-approval/]]></link>
			<title>Sonorous Neurovascular Advances Care with BosCATH Approval</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 08:37:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/amneal-accelerates-growth-with-kashiv-biosciences-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/amneal-accelerates-growth-with-kashiv-biosciences-deal/]]></link>
			<title>Amneal Accelerates Growth with Kashiv BioSciences Deal</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 06:25:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/regeneron-cemdisiran-shows-strong-gmg-phase-3-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/regeneron-cemdisiran-shows-strong-gmg-phase-3-results/]]></link>
			<title>Regeneron Cemdisiran Shows Strong gMG Phase 3 Results</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 06:02:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/sanofi-secures-fda-approval-for-tzield-in-young-t1d/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/sanofi-secures-fda-approval-for-tzield-in-young-t1d/]]></link>
			<title>Sanofi Secures FDA Approval for Tzield in Young T1D</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 05:27:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/merck-fda-approval-of-idvynso-hiv-treatment-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/merck-fda-approval-of-idvynso-hiv-treatment-drug/]]></link>
			<title>Merck FDA Approval of IDVYNSO HIV Treatment Drug</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 05:22:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/neurocrine-shows-crenessity-sustains-cah-control-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/neurocrine-shows-crenessity-sustains-cah-control-data/]]></link>
			<title>Neurocrine Shows CRENESSITY Sustains CAH Control Data</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 05:17:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/vicore-pharma-completes-aspire-trial-enrollment-in-ipf/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/vicore-pharma-completes-aspire-trial-enrollment-in-ipf/]]></link>
			<title>Vicore Pharma Completes ASPIRE Trial Enrollment in IPF</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 05:12:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/envoy-medical-acclaim-implant-trial-hits-key-milestone/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/envoy-medical-acclaim-implant-trial-hits-key-milestone/]]></link>
			<title>Envoy Medical Acclaim Implant Trial Hits Key Milestone</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 05:05:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/labcorp-enables-keytruda-access-with-fda-diagnostic/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/labcorp-enables-keytruda-access-with-fda-diagnostic/]]></link>
			<title>Labcorp Enables KEYTRUDA Access with FDA Diagnostic</title>
			<pubDate><![CDATA[Thu, 23 Apr 2026 04:54:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/apotex-expands-u-s-portfolio-via-cumberland-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/apotex-expands-u-s-portfolio-via-cumberland-deal/]]></link>
			<title>Apotex Expands U.S. Portfolio via Cumberland Deal</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 04:56:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/cipla-strengthens-global-pharma-leadership-and-access/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/cipla-strengthens-global-pharma-leadership-and-access/]]></link>
			<title>Cipla Strengthens Global Pharma Leadership and Access</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 04:48:47 +0000]]></pubDate>
		</item>
				</channel>
</rss>
